March 22, 2019
2 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: New brand of loteprednol has increased penetration
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEW YORK – Marc Bloomenstein, OD, said he uses Kala’s new Inveltys (loteprednol etabonate ophthalmic suspension 1%) in both cataract and refractive surgery patients.
It is an “amplified version of loteprednol that makes the molecules much smaller and allows them to traverse through the mucin of the tears and penetrate into the anterior chamber at a significantly higher concentration,” he said. “At a cataract and refractive surgery center, one thing we’re always looking for is something with a low incidence of causing sequalae but a high potential of penetration into the eye, especially with a steroid.”